These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19738610)

  • 1. Effects of VEGFR-3 phosphorylation inhibitor on lymph node metastasis in an orthotopic diffuse-type gastric carcinoma model.
    Yashiro M; Shinto O; Nakamura K; Tendo M; Matsuoka T; Matsuzaki T; Kaizaki R; Ohira M; Miwa A; Hirakawa K
    Br J Cancer; 2009 Oct; 101(7):1100-6. PubMed ID: 19738610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.
    Kodera Y; Katanasaka Y; Kitamura Y; Tsuda H; Nishio K; Tamura T; Koizumi F
    Breast Cancer Res; 2011 Jun; 13(3):R66. PubMed ID: 21693010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of VEGFR-3 signaling inhibits lymph node metastasis in gastric cancer.
    Shimizu K; Kubo H; Yamaguchi K; Kawashima K; Ueda Y; Matsuo K; Awane M; Shimahara Y; Takabayashi A; Yamaoka Y; Satoh S
    Cancer Sci; 2004 Apr; 95(4):328-33. PubMed ID: 15072591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anlotinib suppresses lymphangiogenesis and lymphatic metastasis in lung adenocarcinoma through a process potentially involving VEGFR-3 signaling.
    Qin T; Liu Z; Wang J; Xia J; Liu S; Jia Y; Liu H; Li K
    Cancer Biol Med; 2020 Aug; 17(3):753-767. PubMed ID: 32944404
    [No Abstract]   [Full Text] [Related]  

  • 5. A novel molecular targeting compound as K-samII/FGF-R2 phosphorylation inhibitor, Ki23057, for Scirrhous gastric cancer.
    Nakamura K; Yashiro M; Matsuoka T; Tendo M; Shimizu T; Miwa A; Hirakawa K
    Gastroenterology; 2006 Nov; 131(5):1530-41. PubMed ID: 17101326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination effect of a TGF-beta receptor kinase inhibitor with 5-FU analog S1 on lymph node metastasis of scirrhous gastric cancer in mice.
    Shinto O; Yashiro M; Kawajiri H; Shimizu K; Shimizu T; Miwa A; Hirakawa K
    Cancer Sci; 2010 Aug; 101(8):1846-52. PubMed ID: 20518790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic antitumor effects of FGFR2 inhibitor with 5-fluorouracil on scirrhous gastric carcinoma.
    Yashiro M; Shinto O; Nakamura K; Tendo M; Matsuoka T; Matsuzaki T; Kaizaki R; Miwa A; Hirakawa K
    Int J Cancer; 2010 Feb; 126(4):1004-16. PubMed ID: 19621385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via reduction of lymphangiogenesis.
    Iwata C; Kano MR; Komuro A; Oka M; Kiyono K; Johansson E; Morishita Y; Yashiro M; Hirakawa K; Kaminishi M; Miyazono K
    Cancer Res; 2007 Nov; 67(21):10181-9. PubMed ID: 17974958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-metastatic Efficacy of Traditional Chinese Medicine (TCM) Ginsenoside Conjugated to a VEFGR-3 Antibody on Human Gastric Cancer in an Orthotopic Mouse Model.
    Dai X; Liu D; Liu M; Zhang X; Wang W; Jin F; Qian Y; Wang X; Zhao J; Wu Y; Xiong F; Chang NA; Sun YU; Yang Z; Hoffman RM; Liu Y
    Anticancer Res; 2017 Mar; 37(3):979-986. PubMed ID: 28314255
    [No Abstract]   [Full Text] [Related]  

  • 10. Liposomal honokiol inhibits VEGF-D-induced lymphangiogenesis and metastasis in xenograft tumor model.
    Wen J; Fu AF; Chen LJ; Xie XJ; Yang GL; Chen XC; Wang YS; Li J; Chen P; Tang MH; Shao XM; Lu Y; Zhao X; Wei YQ
    Int J Cancer; 2009 Jun; 124(11):2709-18. PubMed ID: 19219913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of inhibiting the lymph node metastasis in human gastric carcinoma by B7-1 gene transfection.
    Sakate Y; Yashiro M; Tanaka H; Sunami T; Kosaka K; Hirakawa K
    J Surg Res; 2004 Nov; 122(1):89-95. PubMed ID: 15522320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.
    García-Caballero M; Paupert J; Blacher S; Van de Velde M; Quesada AR; Medina MA; Noël A
    J Hematol Oncol; 2017 Jun; 10(1):122. PubMed ID: 28629427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of vascular endothelial growth factor-D expression and VEGFR-3-positive vessel density with lymph node metastasis in gastric carcinoma.
    Choi JH; Oh YH; Park YW; Baik HK; Lee YY; Kim IS
    J Korean Med Sci; 2008 Aug; 23(4):592-7. PubMed ID: 18756043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.
    Liu ZY; Qiu HO; Yuan XJ; Ni YY; Sun JJ; Jing W; Fan YZ
    Int J Oncol; 2012 Nov; 41(5):1762-72. PubMed ID: 22922710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases.
    Wang XL; Fang JP; Tang RY; Chen XM
    BMC Cancer; 2010 Jun; 10():299. PubMed ID: 20565772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-kinase inhibitor E7080 suppresses lymph node and lung metastases of human mammary breast tumor MDA-MB-231 via inhibition of vascular endothelial growth factor-receptor (VEGF-R) 2 and VEGF-R3 kinase.
    Matsui J; Funahashi Y; Uenaka T; Watanabe T; Tsuruoka A; Asada M
    Clin Cancer Res; 2008 Sep; 14(17):5459-65. PubMed ID: 18765537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody.
    Pytowski B; Goldman J; Persaud K; Wu Y; Witte L; Hicklin DJ; Skobe M; Boardman KC; Swartz MA
    J Natl Cancer Inst; 2005 Jan; 97(1):14-21. PubMed ID: 15632376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.
    He Y; Kozaki K; Karpanen T; Koshikawa K; Yla-Herttuala S; Takahashi T; Alitalo K
    J Natl Cancer Inst; 2002 Jun; 94(11):819-25. PubMed ID: 12048269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of rosiglitazone on the growth and lymphangiogenesis of human gastric cancer transplanted in nude mice.
    Chen FZ; Mo XM; Wang QP; Li J; Zhang L
    Oncol Rep; 2013 Dec; 30(6):2705-12. PubMed ID: 24002492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-O-Acetyloleanolic acid inhibits VEGF-A-induced lymphangiogenesis and lymph node metastasis in an oral cancer sentinel lymph node animal model.
    Hwang-Bo J; Bae MG; Park JH; Chung IS
    BMC Cancer; 2018 Jul; 18(1):714. PubMed ID: 29976150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.